Back to CRNX
FARALLON CAPITAL MANAGEMENT, L.L.C. → CRNX
FARALLON CAPITAL MANAGEMENT, L.L.C. CRNX Position History
Crinetics Pharmaceuticals Inc • Healthcare
Quarters held
14
Latest value
$336.4M
Q2 2026
Peak value
$336.4M
First seen
Q3 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2023 | $10.8M |
| Q4 2023 | $4.4M |
| Q1 2024 | $234K |
| Q1 2024 | $234K |
| Q2 2024 | $22.3M |
| Q3 2024 | $59.4M |
| Q4 2024 | $208.4M |
| Q1 2025 | $154.5M |
| Q2 2025 | $133.6M |
| Q3 2025 | $240.3M |
| Q3 2025 | $240.3M |
| Q4 2025 | $322.7M |
| Q1 2026 | $302.8M |
| Q2 2026 | $336.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $336.4M | 8.99M | — | — |
| Q1 2026 | $302.8M | 8.34M | — | — |
| Q4 2025 | $322.7M | 6.93M | — | — |
| Q3 2025 | $240.3M | 5.77M | — | — |
| Q3 2025 | $240.3M | 5.77M | — | — |
| Q2 2025 | $133.6M | 4.65M | — | — |
| Q1 2025 | $154.5M | 4.61M | — | — |
| Q4 2024 | $208.4M | 4.08M | — | — |
| Q3 2024 | $59.4M | 1.16M | — | — |
| Q2 2024 | $22.3M | 497.0K | — | — |
| Q1 2024 | $234K | 5.0K | — | — |
| Q1 2024 | $234K | 5.0K | — | — |
| Q4 2023 | $4.4M | 122.9K | — | — |
| Q3 2023 | $10.8M | 361.9K | — | — |